BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 21315533)

  • 1. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging.
    Noguchi T; Kawashima M; Irie H; Ootsuka T; Nishihara M; Matsushima T; Kudo S
    Eur J Radiol; 2011 Dec; 80(3):e557-62. PubMed ID: 21315533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive method for mapping CVR in moyamoya disease using ASL-MRI.
    Noguchi T; Kawashima M; Nishihara M; Egashira Y; Azama S; Irie H
    Eur J Radiol; 2015 Jun; 84(6):1137-43. PubMed ID: 25816991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
    Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
    Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial spin-labeling magnetic resonance imaging after revascularization of moyamoya disease.
    Sugino T; Mikami T; Miyata K; Suzuki K; Houkin K; Mikuni N
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):811-6. PubMed ID: 22721824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial transit artifacts observed by arterial spin labeling in Moyamoya disease.
    Ukai R; Mikami T; Nagahama H; Wanibuchi M; Akiyama Y; Miyata K; Mikuni N
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105058. PubMed ID: 32807463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of delayed transit time on arterial spin labeling: correlation with dynamic susceptibility contrast perfusion magnetic resonance in moyamoya disease.
    Yun TJ; Sohn CH; Han MH; Kang HS; Kim JE; Yoon BW; Paeng JC; Choi SH; Kim JH; Song IC; Chang KH
    Invest Radiol; 2013 Nov; 48(11):795-802. PubMed ID: 23764569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
    Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
    Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial Spin Labeling Perfusion Magnetic Resonance Image with Dual Postlabeling Delay: A Correlative Study with Acetazolamide Loading (123)I-Iodoamphetamine Single-Photon Emission Computed Tomography.
    Haga S; Morioka T; Shimogawa T; Akiyama T; Murao K; Kanazawa Y; Sayama T; Arakawa S
    J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):1-6. PubMed ID: 26387043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged Mean Transit Time Detected by Dynamic Susceptibility Contrast Magnetic Resonance Imaging Predicts Cerebrovascular Reserve Impairment in Patients with Moyamoya Disease.
    Kawano T; Ohmori Y; Kaku Y; Muta D; Uekawa K; Nakagawa T; Amadatsu T; Kasamo D; Shiraishi S; Kitajima M; Kuratsu J
    Cerebrovasc Dis; 2016; 42(1-2):131-8. PubMed ID: 27088711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between severity of carotid stenosis and vascular reserve measured by acetazolamide brain perfusion single photon emission computed tomography.
    Tomura N; Otani T; Koga M; Ishiyama K
    J Stroke Cerebrovasc Dis; 2013 Feb; 22(2):166-70. PubMed ID: 21903415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring Cerebral Perfusion Changes after Revascularization in Patients with Moyamoya Disease by Using Arterial Spin-labeling MR Imaging.
    Lee S; Yun TJ; Yoo RE; Yoon BW; Kang KM; Choi SH; Kim JH; Kim JE; Sohn CH; Han MH
    Radiology; 2018 Aug; 288(2):565-572. PubMed ID: 29714677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation study of a pulsed arterial spin labeling technique by comparison to perfusion computed tomography.
    Koziak AM; Winter J; Lee TY; Thompson RT; St Lawrence KS
    Magn Reson Imaging; 2008 May; 26(4):543-53. PubMed ID: 18063336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial spin labeling measurement of cerebral perfusion in children with sickle cell disease.
    Gevers S; Nederveen AJ; Fijnvandraat K; van den Berg SM; van Ooij P; Heijtel DF; Heijboer H; Nederkoorn PJ; Engelen M; van Osch MJ; Majoie CB
    J Magn Reson Imaging; 2012 Apr; 35(4):779-87. PubMed ID: 22095695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel application of four-dimensional magnetic resonance angiography using an arterial spin labeling technique for noninvasive diagnosis of Moyamoya disease.
    Uchino H; Ito M; Fujima N; Kazumata K; Yamazaki K; Nakayama N; Kuroda S; Houkin K
    Clin Neurol Neurosurg; 2015 Oct; 137():105-11. PubMed ID: 26185929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved multislice perfusion imaging with velocity-selective arterial spin labeling.
    Zun Z; Hargreaves BA; Rosenberg J; Zaharchuk G
    J Magn Reson Imaging; 2015 May; 41(5):1422-31. PubMed ID: 24797337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moyamoya disease: evaluation of postoperative revascularization using multiphase selective arterial spin labeling MRI.
    Saida T; Masumoto T; Nakai Y; Shiigai M; Matsumura A; Minami M
    J Comput Assist Tomogr; 2012; 36(1):143-9. PubMed ID: 22261785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative cerebral perfusion imaging in children and young adults with Moyamoya disease: comparison of arterial spin-labeling-MRI and H(2)[(15)O]-PET.
    Goetti R; Warnock G; Kuhn FP; Guggenberger R; O'Gorman R; Buck A; Khan N; Scheer I
    AJNR Am J Neuroradiol; 2014 May; 35(5):1022-8. PubMed ID: 24335546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cerebral blood flow using multi-phase pseudo continuous arterial spin labeling at 3-tesla.
    Sugimori H; Fujima N; Suzuki Y; Hamaguchi H; Sakata M; Kudo K
    Magn Reson Imaging; 2015 Dec; 33(10):1338-1344. PubMed ID: 26260545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced perfusion reserve in Leukoaraiosis demonstrated using acetazolamide challenge 123I-IMP SPECT.
    Tomura N; Sasaki K; Kidani H; Nishii T; Yasuda K; Ishiyama K; Otani T; Sakuma I; Takahashi S; Watarai J; Yanagisawa T; Mizoi K
    J Comput Assist Tomogr; 2007; 31(6):884-7. PubMed ID: 18043350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cerebral perfusion in moyamoya disease with dynamic pseudo-continuous arterial spin labeling using a variable repetition time scheme with optimized background suppression.
    Togao O; Obara M; Yamashita K; Kikuchi K; Arimura K; Nishimura A; Nakamizo A; Wada T; Tokunaga C; Mikayama R; Yamashita Y; Hamano H; Van Cauteren M; Ishigami K; Baba S
    Neuroradiology; 2023 Mar; 65(3):529-538. PubMed ID: 36434310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.